Skip to main content

Table 3 ELISpot IFN-γ activity of CSP peptide pools and individual 15-mer peptides within these pools

From: Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

Pool

Vol.

Vaccine

15mer peptide

AA no.

Sequence

Pool sfc/m

15mer sfc/m

Percent of pool

Cp1

58

Ad-C

C3

9-23

SVSSFLFVEALFQEY

116

29

25.0

Cp1

05

Ad-CA

C3

 

SVSSFLFVEALFQEY

142

65

45.8

Cp1

69

Ad-C

C3

 

SVSSFLFVEALFQEY

411

385

93.7

Cp1

12

Ad-CA

C4

13-27

FLFVEALFQEYQCYG

64

87

135

Cp1

05

Ad-CA

C4

 

FLFVEALFQEYQCYG

142

44

31.0

Cp1

01

Ad-CA

C4

 

FLFVEALFQEYQCYG

77

48

62.3

Cp1

69

Ad-C

C4

 

FLFVEALFQEYQCYG

411

368

89.5

Cp1

58

Ad-C

C5

17-31

EALFQEYQCYGSSSN

116

105

90.5

Cp1

58

Ad-C

C6

21-35

QEYQCYGSSSNTRVL

116

83

71.6

Cp2

49

Ad-C

C8

29-43

SSNTRVLNELNYDNA

64

41

64.1

Cp2

41

Ad-C

C10

37-51

ELNYDNAGTNLYNEL

83

35

42.2

Cp2

49

Ad-C

C12

45-59

TNLYNELEMNYYGKQ

64

28

43.8

Cp2

12

Ad-CA

C12

 

TNLYNELEMNYYGKQ

331

411

124

Cp2

01

Ad-CA

C12

 

TNLYNELEMNYYGKQ

119

119

100

Cp2

01

Ad-CA

C13

49-63

NELEMNYYGKQENWY

119

116

97.5

Cp2

12

Ad-CA

C13

 

NELEMNYYGKQENWY

331

334

100

Cp6

61

Ad-C

C47

313-327

DKHIKEYLNKIQNSL

53

48

90.6

Cp6

41

Ad-C

C48

317-331

KEYLNKIQNSLSTEW

95

103

108

Cp6

05

Ad-CA

C48

 

KEYLNKIQNSLSTEW

130

106

81.5

Cp6

58

Ad-C

C48

 

KEYLNKIQNSLSTEW

24

45

187

Cp9

61

Ad-C

C60

365-379

EKKICKMEKCSSVFN

128

39

30.5

Cp9

01

Ad-CA

C62

373-387

KCSSVFNVVNSSIGL

39

116

297

Cp9

08

Ad-CA

C63

377-391

VFNVVNSSIGLIMVL

142

109

76.8

Cp9

08

Ad-CA

C64

381-395

VNSSIGLIMVLSFLF

142

91

64.1

Cp9

01

Ad-CA

C65

383-397

SSIGLIMVLSFLFLN

39

46

117

Cp9

02

Ad-CA

C65

 

SSIGLIMVLSFLFLN

16

44

275

Cp9

08

Ad-CA

C65

 

SSIGLIMVLSFLFLN

142

62

43.7

  1. All individual 15mer peptides within the CSP peptide pools Cp1, Cp2, Cp6 and Cp9 were tested in ELISpot assay using frozen PBMC collected 28 days after Ad-CA or 19-23 days after Ad-C immunization. 15 individual 15mer peptides of the 26 15mer peptides elicited positive recall responses from at least one volunteer immunized with Ad-CA and Ad-C, and each of the ten volunteers responded positively to at least one 15mer.